Modification of Levodopa Effect by Systemic Decarboxylase Inhibition
- 1 February 1973
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 28 (2) , 91-5
- https://doi.org/10.1001/archneur.1973.00490200039004
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Levodopa, Involuntary Movements and Fusaric AcidJAMA, 1971
- Cerebrospinal fluid monoamine metabolites and peripheral decarboxylase inhibitors in parkinsonismNeurology, 1970
- PREVENTION OR REVERSAL OF LEVODOPA-INDUCED CARDIAC ARRHYTHMIAS BY DECARBOXYLASE INHIBITORSThe Lancet, 1970
- L-Dopa: Effect on Concentrations of Dopamine, Norepinephrine, and Serotonin in Brains of MiceScience, 1970
- The frequency of asymptomatic disturbances of cardiac rhythm and conduction in middle-aged menThe American Journal of Cardiology, 1969
- Modification of Parkinsonism — Chronic Treatment with L-DopaNew England Journal of Medicine, 1969
- Drug-Induced Changes of Extracerebral Dopa Metabolism in ManArchives of Neurology, 1969
- The fluorometric assay of catecholamines and related compounds: Improvements and extensions to the hydroxyindole techniqueAnalytical Biochemistry, 1968
- The Estimation of Total (Free + Conjugated) Catecholamines and Some Catecholamine Metabolites in Human UrinePublished by Wiley ,1968